Renu Eapen

754 total citations
37 papers, 412 citations indexed

About

Renu Eapen is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Renu Eapen has authored 37 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 12 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Surgery. Recurrent topics in Renu Eapen's work include Prostate Cancer Treatment and Research (24 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Renu Eapen is often cited by papers focused on Prostate Cancer Treatment and Research (24 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Renu Eapen collaborates with scholars based in Australia, United States and Germany. Renu Eapen's co-authors include Sidney B. Radomski, Matthew R. Cooperberg, Declan G. Murphy, Nathan Lawrentschuk, Michael S. Hofman, Samuel L. Washington, Annika Herlemann, Arun Azad, Tatenda Nzenza and Marlon Perera and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Renu Eapen

29 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renu Eapen Australia 11 214 134 117 97 65 37 412
Martin Umbehr Switzerland 12 446 2.1× 122 0.9× 160 1.4× 224 2.3× 66 1.0× 23 692
Sebastiaan Remmers Netherlands 14 555 2.6× 38 0.3× 130 1.1× 105 1.1× 22 0.3× 76 643
Paul Schellhammer United States 12 410 1.9× 62 0.5× 77 0.7× 52 0.5× 17 0.3× 23 530
Clara Cerrato Italy 12 344 1.6× 54 0.4× 68 0.6× 38 0.4× 41 0.6× 70 523
Kari T. Syvänen Finland 12 198 0.9× 28 0.2× 67 0.6× 61 0.6× 20 0.3× 34 359
M. Lykourinas Greece 12 220 1.0× 62 0.5× 40 0.3× 51 0.5× 21 0.3× 23 434
Myung Soo Kim South Korea 9 132 0.6× 44 0.3× 43 0.4× 24 0.2× 34 0.5× 24 235
Lukas Manka Germany 12 301 1.4× 20 0.1× 64 0.5× 67 0.7× 19 0.3× 28 414
Riccardo Mastroianni Italy 16 345 1.6× 225 1.7× 58 0.5× 42 0.4× 40 0.6× 86 721
Eugenio Martorana Italy 13 435 2.0× 102 0.8× 151 1.3× 160 1.6× 9 0.1× 40 522

Countries citing papers authored by Renu Eapen

Since Specialization
Citations

This map shows the geographic impact of Renu Eapen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renu Eapen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renu Eapen more than expected).

Fields of papers citing papers by Renu Eapen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renu Eapen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renu Eapen. The network helps show where Renu Eapen may publish in the future.

Co-authorship network of co-authors of Renu Eapen

This figure shows the co-authorship network connecting the top 25 collaborators of Renu Eapen. A scholar is included among the top collaborators of Renu Eapen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renu Eapen. Renu Eapen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ali, Muhammad Shaiq, Mathias Bressel, Declan G. Murphy, et al.. (2025). Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma. British Journal of Urology. 136(4). 719–727.
2.
Eapen, Renu, et al.. (2025). The role of PSMA PET / CT in staging patients with intermediate‐risk prostate cancer. British Journal of Urology. 137(1). 49–57.
3.
4.
Chong, Bryan, Marniza Saad, Tsung Wen Chong, et al.. (2025). Selective treatment de‐escalation in advanced prostate cancer: have we come full circle?. British Journal of Urology. 135(5). 733–740. 1 indexed citations
5.
Ali, Muhammad, Kendrick Koo, Daniel Moon, et al.. (2024). Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer. Radiation Oncology. 19(1). 23–23. 2 indexed citations
6.
Eapen, Renu, Scott Williams, Sean Macdonald, et al.. (2024). Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer. Nature Reviews Urology. 21(11). 676–686. 6 indexed citations
7.
Bates, Anthony S., David A. Braun, Renu Eapen, et al.. (2024). Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology. European Urology. 87(1). 8–14. 5 indexed citations
8.
Saffar, Haidar Al, David C. Chen, Michael S. Hofman, et al.. (2024). The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer. Cancers. 16(5). 939–939. 8 indexed citations
9.
Udovicich, Cristian, Angela Y. Jia, Andrew Loblaw, et al.. (2024). Evolving Paradigms in Prostate Cancer: The Integral Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging and Therapeutic Decision-Making. International Journal of Radiation Oncology*Biology*Physics. 121(2). 307–316. 3 indexed citations
10.
11.
Sutherland, Duncan E. K., Arun Azad, Declan G. Murphy, et al.. (2023). Role of FDG PET/CT in Management of Patients with Prostate Cancer. Seminars in Nuclear Medicine. 54(1). 4–13. 20 indexed citations
12.
Ali, Muhammad, Simon Wood, David Pryor, et al.. (2023). NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial. Contemporary Clinical Trials Communications. 33. 101145–101145. 4 indexed citations
13.
Udovicich, Cristian, Jason Callahan, Mathias Bressel, et al.. (2022). Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma. European Urology Open Science. 44. 60–68. 33 indexed citations
14.
Nzenza, Tatenda, Renu Eapen, Nieroshan Rajarubendra, et al.. (2020). Review of the use of prophylactic drain tubes post‐robotic radical prostatectomy: Dogma or decent practice?. BJUI Compass. 1(4). 122–125. 6 indexed citations
15.
Eapen, Renu, et al.. (2020). The Clinical Applications of Serum and Urinary Biomarkers in Prostate Cancer. SHILAP Revista de lepidopterología. 1(1). 30–38. 2 indexed citations
16.
Holmes, Amy, B.D. Kelly, Marlon Perera, et al.. (2020). A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer. World Journal of Urology. 39(2). 297–306. 12 indexed citations
17.
Eapen, Renu, Tatenda Nzenza, Declan G. Murphy, et al.. (2018). PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics. World Journal of Urology. 37(7). 1255–1261. 34 indexed citations
18.
Eapen, Renu, Annika Herlemann, Samuel L. Washington, & Matthew R. Cooperberg. (2017). Impact of the United States Preventive Services Task Force ‘D’ recommendation on prostate cancer screening and staging. Current Opinion in Urology. 27(3). 205–209. 38 indexed citations
19.
Eapen, Renu & Sidney B. Radomski. (2016). Gender differences in overactive bladder.. PubMed. 23(Suppl 1). 2–9. 21 indexed citations
20.
Eapen, Renu & Sidney B. Radomski. (2016). Review of the epidemiology of overactive bladder. Research and Reports in Urology. 8. 71–71. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Umbehr Breakdown of academic impact, for papers by Sebastiaan Remmers Breakdown of academic impact, for papers by Paul Schellhammer Breakdown of academic impact, for papers by Clara Cerrato Breakdown of academic impact, for papers by Kari T. Syvänen Breakdown of academic impact, for papers by M. Lykourinas Breakdown of academic impact, for papers by Myung Soo Kim Breakdown of academic impact, for papers by Lukas Manka Breakdown of academic impact, for papers by Riccardo Mastroianni Breakdown of academic impact, for papers by Eugenio Martorana
Rankless by CCL
2026